Do Not Give Ketorolac (Toradol) to This Patient
In an elderly male with chronic subdural hematoma and hematuria, ketorolac is absolutely contraindicated and should not be administered, even as a single dose. This patient has multiple high-risk features that make NSAID use dangerous and potentially life-threatening.
Why Ketorolac is Contraindicated
Active Bleeding (Hematuria)
The presence of hematuria represents active bleeding, which is an absolute contraindication to ketorolac. The FDA drug label explicitly warns against use in patients with bleeding disorders 1. NSAIDs inhibit platelet function and can worsen existing hemorrhage 2.
Chronic Subdural Hematoma
This patient has an intracranial bleeding disorder. While one neurosurgical study suggested ketorolac didn't increase symptomatic bleeding requiring surgery after elective craniotomy 3, this evidence:
- Applies only to post-operative elective neurosurgery patients, not patients with existing chronic subdural hematomas
- Had wide confidence intervals that were "not conclusive evidence of safety" per the authors themselves
- Does not address patients with active hematuria or other bleeding
The guidelines clearly state NSAIDs should be used with extreme caution or avoided in patients with bleeding disorders 2.
Elderly Patient with Renal Concerns
Elderly patients (≥60 years) are at high risk for NSAID-related renal toxicity 2. The presence of hematuria may indicate underlying renal pathology, further increasing risk. The FDA label specifically recommends reduced dosing (15 mg IV vs 30 mg IV) for patients ≥65 years 1, but this doesn't make it safe when contraindications exist.
Safer Alternative Approach
Use opioid analgesics instead. The guidelines explicitly state: "Opioid analgesics are safe and effective alternative analgesics to NSAIDs" in high-risk patients 2.
Specific Recommendations:
- First-line: Acetaminophen 650 mg every 4-6 hours (maximum 4 g/day) for mild-moderate pain 2
- For moderate-severe pain: Short-acting opioids (morphine, oxycodone, hydromorphone) titrated to effect
- Avoid: All NSAIDs including ketorolac, ibuprofen, naproxen due to bleeding risk
Critical Pitfalls to Avoid
Don't rationalize "just one dose": Even single-dose ketorolac carries bleeding risk, particularly in patients with pre-existing hemorrhage 1
Don't ignore the hematuria: This represents active bleeding and dramatically increases risk of complications including gastrointestinal bleeding, worsening intracranial hemorrhage, and acute renal failure 1, 4
Don't use selective COX-2 inhibitors as an alternative: While they don't inhibit platelet aggregation, they haven't shown reduced renal side effects and are still contraindicated with active bleeding 2
Risk Profile Summary
The FDA drug label reports dose-dependent serious GI bleeding rates. In elderly patients (≥65 years) receiving >60 mg/day, the rate was 2.8-7.7% even without a history of bleeding 1. Your patient has:
- Advanced age (elderly male)
- Active bleeding (hematuria)
- Intracranial hemorrhagic pathology (chronic subdural hematoma)
This combination creates an unacceptably high risk for catastrophic bleeding complications including expansion of the subdural hematoma, gastrointestinal hemorrhage requiring transfusion, or acute renal failure 1, 4.
The answer is definitively no—use opioids or acetaminophen for pain management in this patient.